Experienced in Felty Syndrome

Blanca E. Cruz-Hernandez

Sevilla, AN, ES 
Experienced in Felty Syndrome
Sevilla, AN, ES 
OverviewLocationsClinical Research

Overview

Blanca Cruz-Hernandez practices in Sevilla, Spain. Ms. Cruz-Hernandez is rated as an Experienced expert by MediFind in the treatment of Felty Syndrome. Her top areas of expertise are Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Arthritis, and Felty Syndrome.

Her clinical research consists of co-authoring 40 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Felty Syndrome.

Gender
Female

Locations

Sevilla, AN, Spain
Other Locations
Las Palmas De Gran Canaria, CN, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Randomized Clinical Trial on the Prevention of Radiographic Progression With Zoledronic Acid in Patients With Early Rheumatoid Arthritis and Low Disease Activity
Randomized Clinical Trial on the Prevention of Radiographic Progression With Zoledronic Acid in Patients With Early Rheumatoid Arthritis and Low Disease Activity
Enrollment Status: Terminated
Publish Date: February 22, 2019
Intervention Type: Drug
Study Phase: Phase 3

40 Total Publications

Response to correspondence about our article Hernández-Cruz B, Otero-Varela L, Freire-González M, Busquets-Pérez N, García González AJ, Moreno-Ramos M, et al. Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry. Ann Rheum Dis. 2024 Aug 27;83(9):1189-99. doi:10.1136/ard-2023-225271.
Response to correspondence about our article Hernández-Cruz B, Otero-Varela L, Freire-González M, Busquets-Pérez N, García González AJ, Moreno-Ramos M, et al. Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry. Ann Rheum Dis. 2024 Aug 27;83(9):1189-99. doi:10.1136/ard-2023-225271.
Journal: Annals of the rheumatic diseases
Published: July 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cruz-Hernandez's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile